Status:
RECRUITING
ACE Acetabular Cup UK Multi-centre PMCF Study
Lead Sponsor:
JRI Orthopaedics
Conditions:
Hip Disease
Eligibility:
All Genders
18+ years
Brief Summary
A total hip replacement is one of the most successful and cost-effective surgical procedures in orthopaedics, and involves replacing both the hip ball and socket. Its goal is to provide pain relief, a...
Eligibility Criteria
Inclusion
- Patients deemed suitable for elective primary THR, as per indications in the IFU.
- Male or female, 18 years or older.
Exclusion
- Patients who are unable to provide written informed consent.
- Patients deemed unsuitable for THR, as per contra-indications in the IFU.
- Patients indicated for THR as a result of trauma (i.e. neck of femur fracture).
- Patients who are pregnant (exclusion criteria for THR in general).
- Patients receiving implants other than the approved combination, i.e. an ACE Acetabular Cup System with a JRI femoral stem and head.
- Patients who are unable to comply with the protocol.
Key Trial Info
Start Date :
June 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2035
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT04123431
Start Date
June 6 2023
End Date
November 1 2035
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Sussex NHS Foundation Trust
Worthing, United Kingdom, BN11 2DH